In the US, Temodar (temozolomide systemic) is a member of the drug class alkylating agents and is used to treat Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme, Melanoma and Melanoma - Metastatic.
US matches:
- Temodar
- Temodar Intravenous
Ingredient matches for Temodar
Temozolomide
Temozolomide is reported as an ingredient of Temodar in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment